Almac and Exco InTouch Form Alliance to Deliver Patient Compliance and ePRO Services Using Multiple Technologies
The Almac Group and Exco InTouch announced that Almac’s Clinical Technologies business unit has formed an exclusive integrated patient management alliance with Exco InTouch, a firm specializing in patient recruitment, retention, compliance, and ePRO services. The alliance will be focused on the integration of both technology and processes by both firms to deliver patient management, compliance, retention, and ePRO service offerings to sponsors of clinical trials.
The Almac-Exco InTouch offering helps to engage, retain, and enhance compliance of patients from the earliest stages of recruitment and throughout the course of a trial. Exco InTouch will work with Almac to integrate its retention and compliance technology solutions with Almac’s IXRS® technology, an integrated phone and web platform. This industry offering will allow patients to receive messages for key elements of their required study conduct using Short Message Service (SMS) text messages, emails, or phone calls. Examples of messages include reminders to attend clinic visits or to fill out patient diaries, medication prompts, notices to attend appointments in a fasted state, to return unused medication, and even encouragement messages to keep all patients motivated to participate in the clinical trial.
The Almac-Exco InTouch alliance offers sponsors the benefit of alleviating clinical trial site personnel of significant administrative burdens and activities relating to protocol compliance. Moreover, it provides biopharmaceutical firms a way to ease a patient’s journey through the clinical trial process using familiar technologies that are both popular and ubiquitous, including phone, web, text messages and email. The solution keeps patients on track during a trial and offers them an “electronic tap on the shoulder” in their native languages to help drive compliance.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
